Bayer A, Gajewska A, Stephens M, et al,
"Pharmacokinetics of Ciprofloxacin in the Elderly," Respiration, 1987,
51(4):292-5.
Campoli-Richards DM, Monk JP, Price A, et al,
"Ciprofloxacin: A Review of Its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Use,"
Drugs, 1988, 35(4):373-447.
Cohen H and Francisco DH,
"Twelve Gram Overdose of Ciprofloxacin With Mild Symptomatology," Ann
Pharmacother, 1994, 28(6):805-6.
Davies SP, Azadian BS, Kox WJ, et al,
"Pharmacokinetics of Ciprofloxacin and Vancomycin in Patients With Acute Renal Failure Treated by Continuous Haemodialysis,"
Nephrol Dial Transplant, 1992, 7(8):848-54.
Davis R, Markham A, and Balfour JA,
"Ciprofloxacin. An Updated Review of Its Pharmacology, Therapeutic Efficacy and Tolerability,"
Drugs, 1996, 51(6):1019-74.
Fish DN, Bainbridge JL, and Peloquin CA,
"Variable Disposition of Ciprofloxacin in Critically Ill Patients Undergoing Continuous Arteriovenous Hemodiafiltration,"
Pharmacotherapy, 1995, 15(2):236-45.
Gamboa F, Rivera JM, Gomez Mateos JM, et al,
"Ciprofloxacin-Induced Henoch-Schönlein Purpura," Ann
Pharmacother, 1995, 29(1):84.
Guay DRP, Awni WM, Peterson PK, et al,
"Single and Multiple Dose Pharmacokinetics of Oral Ciprofloxacin in Elderly Patients,"
Int J Clin Pharmacol Ther Toxicol, 1988, 26(6):279-84.
Guharoy SR, "Serum Sickness Secondary to Ciprofloxacin Use," Vet Hum
Toxicol, 1994, 36(6):540-1.
Hoogkamp-Korstanje JA,
" In vitro Activities of Ciprofloxacin, Levofloxacin, Lomefloxacin, Ofloxacin, Pefloxacin, Sparfloxacin, and Trovafloxacin Against Gram-Positive and Gram-Negative Pathogens From Respiratory Tract Infections,"
J Antimicrob Chemother, 1997, 40(3):427-31.
Hooper DC and Wolfson JS, "Fluoroquinolone Antimicrobial Agents," N Engl J
Med, 1991, 324(6):384-94.
Kapila K, Chysky V, Hullman R, et al,
"Worldwide Clinical Experience on Safety of Ciprofloxacin in Children on Compassionate Use Basis,"
Proceedings of Third International Symposium on New Quinolones, Vancouver,
Canada, 1990, 9.
Lomaestro BM and Bailie GR, "Quinolone-Cation Interactions: A Review,"
DICP, 1991, 25(11):1249-58.
Mackay AD and Mehta A,
"Autoimmune Haemolytic Anemia Associated With Ciprofloxacin," Clin Lab
Haematol, 1995, 17(1):97-8.
Mulhall JP and Bergmann LS, "Ciprofloxacin-Induced Acute Psychosis,"
Urology, 1995, 46(1):102-3.
Nilsson-Ehle I and Ljungberg B,
"Quinolone Disposition in the Elderly: Practical Implications," Drugs
Aging, 1991, 1(4):279-88.
Paul J and Brown NM, "Tinnitus and Ciprofloxacin," BMJ, 1995,
311(6999):232.
Rams TE and Slots J, "Antibiotics in Periodontal Therapy: An Update,"
Compendium, 1992, 13(12):1130, 1132, 1134.
Rfidah EI, Findlay CA, and Beattie TJ,
"Reversible Encephalopathy After Intravenous Ciprofloxacin Therapy," Pediatr
Nephrol, 1995, 9(2):250-1.
Rodriguez WJ, and Wiedermann BL,
"The Role of Newer Oral Cephalosporins, Fluoroquinolones, and Macrolides in the Treatment of Pediatric Infections,"
Adv Pediatr Infect Dis, 1994, 9:125-59.
Rubio TT, Miles MV, Lettieri JT, et al,
"Pharmacokinetic Disposition of Sequential Intravenous/Oral Ciprofloxacin in Pediatric Cystic Fibrosis Patients with Acute Pulmonary Exacerbation,"
Pediatr Infect Dis J, 1997, 16:112-7
Sanders CC,
"Ciprofloxacin: In Vitro Activity, Mechanism of Action, and Resistance,"
Rev Infect Dis, 1988, 10(3):516-27.
Schaad UB, abdus Salam M, Aujard Y, et al,
"Use of Fluoroquinolones in Pediatrics: Consensus Report of an International Society of Chemotherapy Commission,"
Pediatr Infect Dis J, 1995, 14(1):1-9.
Stein GE, "The 4-Quinolone Antibiotics: Past, Present, and Future,"
Pharmacotherapy, 1988, 8(6):301-14.
Sudip RG, "Serum Sickness Secondary to Ciprofloxacin Use," Vet Hum
Toxicol, 36(6):540-1, 1994.
Szarfman A, Chen M, and Blum MD,
"More on Fluoroquinolone Antibiotics and Tendon Rupture," N Engl J Med,
1995, 332(3):193.
Villenueve JP, Davies C, and Cote J,
"Suspected Ciprofloxacin-Induced Hepatotoxicity," Ann Pharmacother, 1995,
29(3):257-9.
Walker RC and Wright AJ, "The Fluoroquinolones," Mayo Clin Proc, 1991,
66(12):1249-59.
Yew WW, Chau CH, Wong PC, et al,
"Ciprofloxacin-Induced Renal Dysfunction in Patients With Mycobacterial Lung Infections,"
Tuber Lung Dis, 1995, 76(2):173-5.